Deerland Probiotics & Enzymes is a global provider of probiotic and dietary supplements, including 12 branded product lines. The company’s products and solutions include spore probiotics, which offer enhanced stability for a wider use in food and beverage, pet nutrition and supplement applications. Deerland operates five manufacturing facilities, one fermentation facility and eight research and development and quality control laboratories globally, ADM said.

“The hand-in-glove fit of Deerland’s vast portfolio of branded technologies, clinical studies and world-class dosage-form production capabilities combined with ADM’s health and wellness solutions is strong and unparalleled, allowing us to provide our dietary supplement, food/beverage and companion animal customers with a much broader array of products and capabilities,” said Scott Ravech, Deerland Probiotics & Enzymes’ CEO. “The Deerland team could not be more excited at the opportunity to be a part of the ADM family.”

The Deerland acquisition is the latest in a series of ADM strategic investments to build a full-scale global Health & Wellness business to help meet fast-growing demand for food, beverages and supplements that enhance health and wellbeing, the company said. The transaction, which is subject to regulatory approval, is expected to be completed in the coming weeks; when that occurs, Deerland’s approximately 320 colleagues will transfer to ADM.